GSK CEO says RSV vaccine revenue to top 1 bln pounds in first year

cafead

Administrator
Staff member
  • cafead   Nov 30, 2023 at 11:22: PM
via
  • GSK shares have lagged rivals in recent years
  • Zantac litigation 'clear overhang' on stock-CEO
  • Walmsley defends GSK's work on drug pipeline
  • RSV vaccine data for U.S. for 50-59 year olds by year-end-CEO

article source